Varicella, live attenuated

Therapeutic indications

Varicella, live attenuated is indicated for:

Active immunisation against varicella

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

The varicella vaccine (live) is indicated for active immunisation against varicella:

In healthy individuals from 9 to 11 months of age, under special circumstances;
In healthy individuals from the age of 12 months;
For post-exposure prophylaxis if administered to healthy, susceptible individuals exposed to varicella within 72 hours of contact;
In individuals at high risk of severe varicella.

The use of the vaccine should be based on official recommendations.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

2 doses with an interval of 3 months

2 doses with an interval of 6 weeks

Contraindications

Varicella, live attenuated is contraindicated in the following cases:

Pregnancy

Lactation

Severe humoral immunodeficiency, severe cellular immunodeficiency

at least one of

Humoral immune defect
Cellular immune defect

Acute severe febrile illness

Disorder characterized by fever

Live attenuated vaccines

Live organism vaccines

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.